home / stock / rsls / rsls news


RSLS News and Press, ReShape Lifesciences Inc. From 05/09/24

Stock Information

Company Name: ReShape Lifesciences Inc.
Stock Symbol: RSLS
Market: OTC

Menu

RSLS RSLS Quote RSLS Short RSLS News RSLS Articles RSLS Message Board
Get RSLS Alerts

News, Short Squeeze, Breakout and More Instantly...

RSLS - ReShape Lifesciences files to sell 11.7M common shares for holders

2024-05-09 12:22:56 ET More on ReShape Lifesciences ReShape Lifesciences gets notice of allowance for additional U.S. patent ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan Read the full article on Seeking Alpha For further det...

RSLS - ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

Completed First Surgeries With Next-Generation Lap-Band ® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., April 01, 2024...

RSLS - ReShape Lifesciences gets notice of allowance for additional U.S. patent

2024-03-28 08:56:46 ET More on ReShape Lifesciences ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earnings data for ReShape Lifesciences Financial informa...

RSLS - ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for...

RSLS - ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for Synergistic M&A Partner Continues IRVINE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® ...

RSLS - ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX

IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that bariatric surgical fellows from the University of Texas Health Center in Houston, Texas were...

RSLS - Anti-obesity meds can expand the market for weight loss surgery: Bernstein

2024-01-21 12:00:01 ET More on Intuitive Surgical, J&J, etc. Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuit...

RSLS - ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex

(NewsDirect) ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration. Hickey told Proactive this FDA approval represents ...

RSLS - ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives

IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it has engaged Maxim Group LLC, to act as the Company’s exclusive financial advisor to ...

RSLS - They're Back- 24/7 Market News Wrap 13 Dec 2023

2023-12-13 18:29:59 ET DENVER, Colo., Dec. 13, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Shattuck Labs Inc (NASDAQ: STTK), Reshape Lifesciences Inc (NASDAQ: RSLS), C4 Therapeutics Inc. (NASDAQ: CCCC), Chanson International Holding (NASDAQ: C...

Previous 10 Next 10